|
**Overview**: Rheumatoid Autoimmune Panel**Introduction**: The Rheumatoid Autoimmune Panel is a diagnostic tool designed for comprehensive rheumatoid screening using serum samples. In India, RA and overlapping autoimmune diseases (SLE, Sjogren's) cause significant disability, with early diagnosis improving outcomes. High morbidity from under-testing in rural/low-SES patients with polyarthritis or systemic symptoms, limited multi-autoantibody labs, delayed DMARDs or biologics leading to joint destruction. Per rheumatology practices aligned with ICMR and Indian Rheumatology Association guidelines, the test employs immunoassay for rheumatoid factor, anti-CCP, ANA, ESR, CRP, anti-dsDNA, and C3 over 1-2 days with high accuracy, valuable for differentiating RA from mimics and assessing disease activity. This diagnostic falls under autoimmune screening and targets patients with joint pain, rash, or fatigue, addressing accurate detection to guide targeted therapy. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling comprehensive autoimmune profiling and reducing disability burden. Its serum-based approach ensures reliable multi-marker assessment.**Other Names**: RA Autoimmune Pnl.**FDA Status**: FDA approved, CLIA certified for immunology, compliant with 2025 standards.**Historical Milestone**: Multi-autoantibody panel standard in rheumatology; in India, used in tertiary centers.**Purpose**: The test assesses 7 parameters including rheumatoid factor to guide comprehensive autoimmune screening, detect RA/SLE markers, inform therapy.**Test Parameters**: 1. Rheumatoid Factor, 2. Anti-CCP, 3. ANA, 4. ESR, 5. CRP, 6. Anti-dsDNA, 7. C3.**Pretest Condition**: Fasting 10-12 hours recommended; patients should have joint/systemic symptoms.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on joint pain, rash, fatigue.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected autoimmune disease including disability, benefits of screening, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Positive anti-CCP/RF + high ESR/CRP supports active RA; anti-dsDNA/C3 abnormal suggests SLE overlap, necessitating specialist input.**Specialist Consultation**: Rheumatologists should be consulted for management.**Additional Supporting Tests**: Joint X-ray, complement levels for confirmation.**Test Limitations**: Overlap syndromes possible; comprehensive approach required.**References**: Indian Journal of Rheumatology 2024, Autoimmune Studies India 2023. |
